Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor

International Journal of Radiation Oncology, Biology, Physics
Jin Ho KimIl Han Kim

Abstract

Histone deacetylase inhibitors (HDAC-Is) show in vitro and in vivo antitumor activity in various types of cancer cells and are being studied in clinical trials. However, studies addressing the combination of HDAC-I and radiation are lacking. The purpose of this study was to assess the effect of trichostatin A (TSA), an HDAC-I, on the radiosensitivity of U373MG and U87MG (human glioblastoma) cell lines. Intrinsic TSA toxicity was determined by measuring survival in exponentially growing cells treated with 0-200 nM TSA for 0-24 h. To assay the radiosensitizing effect of TSA, cells were exposed to 0-200 nM TSA for 18 h before irradiation, and radiation survival curves were obtained. Radiation survival of TSA-treated cells was determined by clonogenic assay. The human glioblastoma cells showed a dose-dependent reduction in survival and radiosensitization with TSA treatment in the range of 50-200 nM. Exposure to 200 nM TSA resulted in reduced survival of both cell lines, and survival was further reduced with time. Exposure of these cells to TSA before irradiation led to dose-dependent radiosensitization. These results suggest that HDAC-Is may be a useful adjunct in the treatment of glioblastoma and merit further investigation. Given...Continue Reading

References

Apr 16, 1998·International Journal of Radiation Oncology, Biology, Physics·K NakagawaA Akanuma
Sep 23, 1998·Genes & Development·K SakaguchiE Appella
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·A SaitoO Nakanishi
Mar 15, 2001·Current Opinion in Cell Biology·D Durocher, S P Jackson
Oct 6, 2001·Cancer Chemotherapy and Pharmacology·M YoshidaS Horinouchi
Oct 24, 2001·Cell·H VaziriR A Weinberg
Oct 30, 2001·International Journal of Radiation Biology·S BiadeJ D Chapman
Jan 5, 2002·International Journal of Cancer. Journal International Du Cancer·Ho Jeong KwonKyu-Won Kim
Nov 12, 2002·The EMBO Journal·Akihiro ItoTso-Pang Yao
Nov 21, 2002·Journal of Experimental Therapeutics & Oncology·John L MarshallMichael J Hawkins
Dec 21, 2002·International Journal of Cancer. Journal International Du Cancer·Yo-ichi YamashitaKeizo Sugimachi
Apr 2, 2003·The Journal of Cell Biology·Gary D KaoTim J Yen

❮ Previous
Next ❯

Citations

Jul 11, 2006·Apoptosis : an International Journal on Programmed Cell Death·Yubin ZhangYasuhisa Shinomura
Sep 7, 2006·Nature Reviews. Drug Discovery·Jessica E BoldenRicky W Johnstone
May 14, 2011·Anti-cancer Drugs·Annette BangertSimone Fulda
Apr 25, 2012·Neurology Research International·James PerryArnab Chakravarti
Sep 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Prakash ChinnaiyanPhilip J Tofilon
Jul 29, 2006·Journal of Neurosurgery·Quincy A Quick, David A Gewirtz
Apr 1, 2005·Cancer Research and Treatment : Official Journal of Korean Cancer Association·In Ah KimCharn Il Park
Jan 28, 2014·Journal of Molecular Neuroscience : MN·Felipe de Almeida SassiRafael Roesler
Jun 1, 2011·Cellular Oncology (Dordrecht)·Elisabeth J ShawCarol Walker
Jan 24, 2014·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Jin Ho KimIn Ah Kim
Oct 29, 2013·Expert Opinion on Investigational Drugs·Lenka ČinčárováJiří Fajkus
May 23, 2015·Acta Neurologica Scandinavica·H A Gefroh-Grimes, B E Gidal
Aug 21, 2007·International Journal of Radiation Oncology, Biology, Physics·Carlos A LopezMats Ljungman
Mar 8, 2007·Annals of the New York Academy of Sciences·Darina ZáskodováAles Tichy
Mar 3, 2011·Journal of Cellular and Molecular Medicine·Jacob E ShabasonKevin Camphausen
Jun 6, 2006·International Journal of Radiation Oncology, Biology, Physics·Yubin ZhangYasuhisa Shinomura
Dec 31, 2005·Neuroscience Letters·Sun-Yong BaekSoo-Kyung Bae
Jan 21, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Eui Kyu ChieIl Han Kim
May 28, 2014·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Kim M SmitsPhilippe Lambin
Mar 3, 2012·International Journal of Radiation Oncology, Biology, Physics·Yen-Shen LuJason Chia-Hsien Cheng
Nov 20, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Jin Ho KimIn Ah Kim
Mar 31, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·In Ah KimEric J Bernhard
Oct 22, 2016·Cellular Oncology (Dordrecht)·Mikkel StabergPetra Hamerlik
Sep 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kevin Camphausen, Philip J Tofilon
Apr 27, 2013·Expert Review of Anticancer Therapy·Brian M AlexanderPatrick Y Wen
Jan 19, 2017·Oncotarget·Dong Hoon LeeSo Hee Kwon
Oct 31, 2008·Radiation Research·Suisui SongJ Martin Brown
Nov 1, 2011·Journal of Neuro-oncology·Krista A Van NifterikLukas J A Stalpers
Nov 18, 2010·Expert Review of Anticancer Therapy·Rafael RoeslerGilberto Schwartsmann
Jul 20, 2020·Journal of Experimental & Clinical Cancer Research : CR·Rui ChenYali Wang
Aug 12, 2005·Molecular Cancer Therapeutics·Ragnhild V NomeAnne Hansen Ree
Nov 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carmen A BanuelosPeggy L Olive
Aug 8, 2021·International Journal of Molecular Sciences·Qiong WuArnold B Etame

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

International Journal of Cancer. Journal International Du Cancer
Kevin CamphausenPhilip J Tofilon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Kevin CamphausenPhilip J Tofilon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Anupama MunshiRaymond E Meyn
© 2022 Meta ULC. All rights reserved